Shares of Evoke plc (LON:EVOK - Get Free Report) were up 17.2% during trading on Tuesday . The stock traded as high as GBX 45.90 ($0.60) and last traded at GBX 44.30 ($0.58). Approximately 3,500,189 shares traded hands during trading, an increase of 35% from the average daily volume of 2,588,063 shares. The stock had previously closed at GBX 37.80 ($0.49).
Wall Street Analysts Forecast Growth
Separately, Jefferies Financial Group reiterated a "buy" rating and set a GBX 140 ($1.83) target price on shares of Evoke in a research report on Monday, December 16th.
Read Our Latest Analysis on EVOK
Evoke Stock Performance
The company has a market capitalization of £207.38 million, a price-to-earnings ratio of -1.16 and a beta of 0.84. The company has a 50 day moving average price of GBX 62.59 and a 200 day moving average price of GBX 62.11.
Evoke (LON:EVOK - Get Free Report) last announced its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. Research analysts forecast that Evoke plc will post 12.7648305 EPS for the current year.
Insider Transactions at Evoke
In other news, insider Andrea Gisle Joosen purchased 14,572 shares of the business's stock in a transaction that occurred on Tuesday, January 28th. The shares were acquired at an average cost of GBX 70 ($0.92) per share, for a total transaction of £10,200.40 ($13,346.07). Also, insider Jonathan (Jon) Mendelsohn acquired 200,000 shares of the firm's stock in a transaction on Monday, March 31st. The stock was purchased at an average price of GBX 48 ($0.63) per share, with a total value of £96,000 ($125,605.13). 27.00% of the stock is currently owned by insiders.
Evoke Company Profile
(
Get Free Report)
See Also
Before you consider Evoke, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.
While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.